
The Active Components of Traditional Chinese Medicines Regulate the Multi-Target Signaling Pathways of Metabolic ...
Introduction With the growing prevalence of obesity and metabolic syndrome, metabolic dysfunction-associated fatty liver disease (MAFLD) has become the main cause of chronic liver disease worldwide. MAFLD affects 30% of adults globally, and its incidence …